KEQU · Kewaunee Scientific Corp /De/
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| International backlog | 47.1M | fiscal year 2026 | — |
| Lab Products Group backlog | 118.8M | fiscal year 2026 | — |
| order backlog | 165.9M | fiscal year 2026 | — |
| Debt-to-equity ratio | 0.68 | Q3 FY2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Furnishings, Fixtures & Appliances — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KEQU
this stock
Kewaunee Scientific Corp /De/
|
$103.36M | -3.7% | +7.7% | 11.2 | 1.7% |
|
MGCLY
Midea Group Co., Ltd./ADR
|
$91.88B | +10.6% | — | — | 0.0% |
|
SN
SharkNinja, Inc.
|
$21.03B | +32.8% | +15.7% | — | 5.9% |
|
SGI
Somnigroup International Inc.
|
$15.05B | -19.5% | +5.5% | 28.6 | 7.1% |
|
NCLTY
Nitori Holdings Co., Ltd.
|
$8.30B | -17.2% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KEQU | -5.5% | +2.5% | -8.9% | +1.4% | -3.7% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -3.8% | +1.8% | -15.3% | +2.5% | -12.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.